Dovato 50-300 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FL077
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,539
Award facts
- Contract value 100% obligated
- $29,538.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $29.5K to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 29, 2026, for the supply of Dovato 50-300 mg tablets in quantities of 30 units. The contract is a firm fixed-price delivery order with an ultimate completion date of January 30, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation and represents a routine pharmaceutical supply order under the company's broader federal medical procurement activities.
This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at $999.9M through December 2026. The parent organization, Cencora, Inc. (doing business as AmerisourceBergen), holds a significant $999.9M IDC with DLA extending through December 2031, which serves as the primary vehicle for supplying a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen's federal contract portfolio demonstrates its role as a critical pharmaceutical distributor serving military treatment facilities, veteran healthcare systems, and other federal medical institutions with brand-name and generic medications across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FL077?
SPE2DR26FL077 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26FL077 worth?
The government has obligated $29,539 on SPE2DR26FL077.
Is contract SPE2DR26FL077 an order under another contract?
Yes. SPE2DR26FL077 is a delivery order under SPE2DR25D1104, an indefinite delivery contract.
Was contract SPE2DR26FL077 competed?
The extent of competition for SPE2DR26FL077 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award